CROI 2023
Long-Acting Injectable ART as Effective as Daily Pills
CAB+RPV LA antiretroviral therapy was as effective as daily BIC/FTC/TAF in maintaining viral suppression among ...
FEBRUARY 23, 2023
Investigational Combo Lenacapavir Plus bNAbs Would Push HIV Treatment to Twice Yearly
The combination of lenacapavir with two broadly neutralizing antibodies was generally well tolerated with high ...
FEBRUARY 23, 2023
Dapivirine Ring Appears Safe for HIV Prevention While Breastfeeding
A monthly vaginal ring containing dapivirine to prevent HIV infection appears to be safe while breastfeeding.
FEBRUARY 23, 2023
Mpox and Severe HIV—A Toxic Relationship
Mpox should be added to the list of AIDS-defining diseases, investigators said. Those with poorly controlled HIV ...
FEBRUARY 22, 2023
Yvette Raphael: Time to Address ‘Unfinished Work’ and Meet Women’s Needs
Despite the strides made in HIV, there is still much work to be done, Yvette Raphael, the cofounder of Advocacy for ...
FEBRUARY 21, 2023
LA-ART Suppresses HIV in Underserved Populations
Comprehensive support services combined with a long-acting antiretroviral treatment given every four to eight weeks ...
FEBRUARY 21, 2023
Fast-Dissolving Suppository Shows Promise for Preventing HIV Through Anal Sex
A fast-dissolving suppository being developed as an “on-demand” HIV prevention method was found to be ...
FEBRUARY 21, 2023
Dr. Fauci to Young Scientists: Take the Ball and Run With It
On the 30th Anniversary of CROI—a meeting he helped found—Dr. Anthony Fauci urged young investigators ...
FEBRUARY 21, 2023
